All terms in GO
| Label | Id | Description |
|---|---|---|
| peptidyl-isoleucine racemization | GO_0019124 |
The racemization of peptidyl-isoleucine.
|
| peptidyl-phenylalanine racemization | GO_0019125 |
The racemization of peptidyl-phenylalanine.
|
| peptidyl-serine racemization | GO_0019126 |
The racemization of peptidyl-serine.
|
| GO_0019127 | GO_0019127 | |
| peptidyl-tryptophan racemization | GO_0019128 |
The racemization of peptidyl-tryptophan.
|
| GO_0034747 | GO_0034747 | |
| peptidyl-leucine racemization | GO_0019129 |
The racemization of peptidyl-leucine.
|
| Par3-APC-KIF3A complex | GO_0034748 |
A protein complex that contains Par3, the tumor suppressor protein adenomatous polyposis coli (APC), and the kinesin-related protein KIF3A; involved in establishing neuronal cell polarity.
|
| APC-IQGAP1-Rac1 complex | GO_0034745 |
A protein complex that contains the tumor suppressor protein adenomatous polyposis coli (APC), the small GTPase Rac1, and the Rac1 and Cdc42 effector IQGAP1; may play a role in cytoskeleton organization and cell migration.
|
| APC-IQGAP1-CLIP-170 complex | GO_0034746 |
A protein complex that contains the tumor suppressor protein adenomatous polyposis coli (APC), the small GTPase Cdc42, and CLIP-170; may play a role in cytoskeleton organization and cell migration.
|
| regulation of multivesicular body size involved in ubiquitin-dependent protein catabolism | GO_0010798 |
Any process that modulates the volume of a multivesicular body as part of the chemical reactions and pathways resulting in the breakdown of a protein or peptide covalently tagged with ubiquitin.
|
| Scrib-APC complex | GO_0034749 |
A protein complex that contains the Scribble protein (a cell polarity determinant) and the tumor suppressor protein adenomatous polyposis coli (APC); may be involved in the control of cell proliferation.
|
| histone H4-K20 dimethylation | GO_0034772 |
The modification of histone H4 by addition of two methyl groups to lysine at position 20 of the histone.
|
| histone H4-K20 methylation | GO_0034770 |
The modification of histone H4 by addition of one or more methyl groups to lysine at position 20 of the histone.
|
| histone H4-K20 trimethylation | GO_0034773 |
The modification of histone H4 by addition of three methyl groups to lysine at position 20 of the histone.
|
| peptidyl-lysine trimethylation | GO_0018023 |
The methylation of peptidyl-lysine to form peptidyl-N6,N6,N6-trimethyl-L-lysine.
|
| histone H4-K20 monomethylation | GO_0034771 |
The modification of histone H4 by addition of one methyl group to lysine at position 20 of the histone.
|
| peptidyl-lysine monomethylation | GO_0018026 |
The methylation of peptidyl-lysine to form peptidyl-N6-methyl-L-lysine.
|
| response to histamine | GO_0034776 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a histamine stimulus. Histamine, the biogenic amine 2-(1H-imidazol-4-yl)ethanamine, is involved in local immune responses as well as regulating physiological function in the gut and acting as a neurotransmitter.
|
| response to organonitrogen compound | GO_0010243 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organonitrogen stimulus. An organonitrogen compound is formally a compound containing at least one carbon-nitrogen bond.
|